Vestal Point Capital’s Lyra Therapeutics LYRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,000	Closed	-$4.98M	–	72
2024 Q1	$4.98M	Sell	16,000 -44,000	-73%	-$13.7M	0.41%	46
2023 Q4	$15.7M	Buy	+60,000	New	+$15.7M	1.67%	21